OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-151620 |   Pharmaceuticals

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Over the Counter (OTC) Drugs And Dietary Supplements Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET

7.1 GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Pfizer Inc.

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Novartis International AG

16.3 Roche Holding AG

16.4 Merck And Co. Inc.

16.5 Sanofi S.A

16.6 Johnson And Johnson

16.7 Gilead Sciences

16.8 GlaxoSmithKline plc.

16.9 Bayer Healthcare AG

16.10 AstraZeneca plc.

16.11 Alacer Corp.

16.12 Alcon Inc.

16.13 Alfresa Pharma Corporation

16.14 Alkalon A/S

16.15 Alliance Healthcare

16.16 Allergan Plc.

16.17 Reckitt Benckiser Plc.

16.18 Bausch And Lomb

16.19 AbbVie Inc.

16.20 The Colgate-Palmolive Company

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Over the Counter (OTC) Drugs And Dietary Supplements Segment by Type
- Analgesic And Pain Relievers
- Dermatological Products
- Cough, Cold, and Flu Products
- Vitamin Supplements
- Mineral Supplements
- Ophthalmic Products
Over the Counter (OTC) Drugs And Dietary Supplements Segment by Application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacy
- Others

Companies

Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck And Co. Inc.
Sanofi S.A
Johnson And Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan Plc.
Reckitt Benckiser Plc.
Bausch And Lomb
AbbVie Inc.
The Colgate-Palmolive Company

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.